Condensed Consolidated Statements of Changes in Redeemable Convertible Preferred Shares and in Stockholders’ Equity (Capital Deficiency) (Unaudited) (Parentheticals) - USD ($) $ in Thousands		3 Months Ended
		Mar. 31, 2024	Mar. 31, 2023
Issuance of common stock under open market sales agreement, net of issuance costs	[1]	$ 1
Issuance of Common Stock and warrants under Private Investment in Public Equity (“PIPE”), net of issuance costs	[1]	$ 1
Common Stock
Issuance of common stock under open market sales agreement, net of issuance costs	[1]		$ 176
Issuance of Common Stock and warrants under Private Investment in Public Equity (“PIPE”), net of issuance costs	[1]		$ 176

[1] See Note 9A.